Health experts and advocates immediately expressed concerns over the limited data backing the strategy, as did executives at Bavarian Nordic, the Danish company that manufactures Jynneos.
The release of text ahead of a House Rules markup on the package is not the final word on the bill and will set off a new wave of lobbying to ensure clients’ priorities are added in or removed.